Ocular Therapeutix Stock Widgets and Gadgets
| OCUL Stock | USD 7.58 0.17 2.19% |
| Intraday Equity Chart Quick Equity Feed Equity Search Quote Ticker Widgets Data Sheet |
Live Stock Ticker Example
- OCUL Ocular Therapeutix
- Latest Why Investors Shouldnt Be Surprised By Ocular Therapeutix, Inc.s PS
- OCUL 7.58 -0.17
- Low 7.53
- High 7.82
- Volume 1 M
- Alpha -0.077
- Beta -0.27
- Return On Equity -0.95
- Return On Asset -0.31
- Operating Margin (2.96) %
- Current Valuation 889.07 M
- Shares Outstanding 159.02 M
- Shares Owned By Insiders 1.00 %
- Shares Owned By Institutions 85.06 %
- Number Of Shares Shorted 11.6 M
- Price To Earning (2.69) X
- Price To Book 3.82 X
- Price To Sales 18.92 X
- Revenue 63.72 M
- Gross Profit (69.54 M)
- EBITDA (176.14 M)
- Net Income (193.51 M)
- Cash And Equivalents 134.54 M
- Cash Per Share 1.75 X
- Total Debt 75.78 M
- Debt To Equity 0.90 %
- Current Ratio 6.14 X
- Book Value Per Share 2.00 X
- Cash Flow From Operations (134.68 M)
- Short Ratio 8.44 X
- Earnings Per Share (1.22) X
- Target Price 17.45
- Number Of Employees 274
- Beta 1.33
- Market Capitalization 1.21 B
- Total Asset 457.94 M
- Retained Earnings (891.08 M)
- Working Capital 399.63 M
- Current Asset 106.98 M
- Current Liabilities 5.38 M
- Net Asset 457.94 M
- Accumulation Distribution 37439.3
- Daily Balance Of Power (0.59)
- Rate Of Daily Change 0.98
- Day Median Price 7.68
- Day Typical Price 7.64
- Price Action Indicator (0.18)
- Period Momentum Indicator (0.17)
- Relative Strength Index 50.18
Market Snapshot Widget Example
DAX Index Germany | 22,462 0.96 | |
Taiwan Weighted Taiwan | 21,603 1.59 | |
PSI 20 Stock Portugal | 6,951 0.75 | |
CROBEX Croatia | 3,329 0.11 | |
Budapest SE Hungary | 91,416 1.41 | |
IDX 30 Jakarta Indonesia | 386.86 0.42 | |
ISEQ 20 Price Ireland | 1,760 1.45 | |
NYSE Comp USA | 19,270 1.35 | |
Tel Aviv 35 Israel | 2,461 0.89 | |
Coreshares Index Tracker South Afric | 1,108 1.95 | |
IPC MEXICO Mexico | 53,173 0.57 | |
KL Technology Malaysia | 50.27 1.32 | |
IBEX 35 Index Spain | 13,309 0.84 | |
SP Merval Argentina | 1,000,000 0.00 | |
Austrian Traded Index Austria | 4,176 2.08 | |
SPASX Dividend Opportunities Australia | 1,661 0.80 | |
HNX 30 Vietnam | 502.01 1.15 | |
Bucharest BET-NG Romania | 1,262 0.07 | |
AMS Small Cap Netherlands | 1,381 0.78 | |
Oslo Exchange Mutual Norway | 1,463 1.34 | |
BEL Small Belgium | 8,418 0.15 | |
Basic Materials Brazil | 5,422 1.55 | |
Swiss Leader Price Switzerland | 2,074 0.42 | |
Fondo Mutuo ETF Chile | 1,563 0.48 | |
Athens General Comp Greece | 1,736 0.6 | |
Stock Exchange Of Thailand | 1,175 1.05 | |
PX Prague Stock Czech Repub | 2,119 1.22 | |
THE PHILIPPINE STOCK Philippines | 6,147 0.13 | |
WIG 30 Poland | 3,505 1.04 | |
BIST Electricity Turkey | 465.96 1.39 |
Investing Ideas
In addition to having Ocular Therapeutix in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Thematic Opportunities
Explore Investment Opportunities
Compare Ocular Therapeutix
Compare Ocular Therapeutix To Peers
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Ocular Therapeutix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. For more information on how to buy Ocular Stock please use our How to buy in Ocular Stock guide.You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ocular Therapeutix. If investors know Ocular will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ocular Therapeutix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.22) | Revenue Per Share | Quarterly Revenue Growth 0.154 | Return On Assets | Return On Equity |
The market value of Ocular Therapeutix is measured differently than its book value, which is the value of Ocular that is recorded on the company's balance sheet. Investors also form their own opinion of Ocular Therapeutix's value that differs from its market value or its book value, called intrinsic value, which is Ocular Therapeutix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ocular Therapeutix's market value can be influenced by many factors that don't directly affect Ocular Therapeutix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ocular Therapeutix's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ocular Therapeutix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ocular Therapeutix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.